- Home
- REXR vs DVA Comparison
REXR vs DVA Comparison
Compare REXR & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- DVA
- Stock Information
- Founded
- REXR 2013
- DVA 1994
- Country
- REXR United States
- DVA United States
- Employees
- REXR N/A
- DVA N/A
- Industry
- REXR Real Estate Investment Trusts
- DVA Misc Health and Biotechnology Services
- Sector
- REXR Real Estate
- DVA Health Care
- Exchange
- REXR Nasdaq
- DVA Nasdaq
- Market Cap
- REXR 8.6B
- DVA 9.7B
- IPO Year
- REXR 2013
- DVA 1995
- Fundamental
- Price
- REXR $40.43
- DVA $140.35
- Analyst Decision
- REXR Hold
- DVA Hold
- Analyst Count
- REXR 9
- DVA 2
- Target Price
- REXR $40.00
- DVA $162.00
- AVG Volume (30 Days)
- REXR 2.0M
- DVA 831.5K
- Earning Date
- REXR 10-15-2025
- DVA 08-05-2025
- Dividend Yield
- REXR 4.26%
- DVA N/A
- EPS Growth
- REXR 11.21
- DVA 8.72
- EPS
- REXR 1.35
- DVA 10.20
- Revenue
- REXR $986,532,000.00
- DVA $13,161,328,000.00
- Revenue This Year
- REXR $9.25
- DVA $6.51
- Revenue Next Year
- REXR $6.55
- DVA $3.41
- P/E Ratio
- REXR $30.00
- DVA $13.77
- Revenue Growth
- REXR 13.72
- DVA 5.09
- 52 Week Low
- REXR $29.68
- DVA $126.07
- 52 Week High
- REXR $52.61
- DVA $179.60
- Technical
- Relative Strength Index (RSI)
- REXR 68.99
- DVA 55.30
- Support Level
- REXR $38.81
- DVA $133.12
- Resistance Level
- REXR $39.86
- DVA $135.58
- Average True Range (ATR)
- REXR 0.78
- DVA 3.67
- MACD
- REXR 0.31
- DVA 0.78
- Stochastic Oscillator
- REXR 94.59
- DVA 90.96
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.